Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Comment by Pareto8020on Oct 03, 2020 9:16am
270 Views
Post# 31662714

RE:Coincidence or TFC-1067? thks to moooonca.....

RE:Coincidence or TFC-1067? thks to moooonca.....

Great find!  Given SBM shareholders have been trained to be built up to expect news and then have the rug pulled out from underneath us for years now I was skeptical that their TFC-1067 was finally hitting the market.

But the recent run-up on no news combined with the R&F agents posts seems to really be pointing to their TFC-1067 finally hitting the market!  I am only going to allow myself to get moderately excited but after numerous years I guess it had to happen dispite managements repeated fumbles and over-promising and no delivering routine! 

Once it does hit the market and is a success and other major companies find out they can get their hands on R&F's new hot ingredient that should really spur on further contracts which should be at exponentially higher levels than they gave it to R&F.  If they can follow up this launch with some addtional news say an  animal diabetes contract or finalizing Phase 1 of the SGLT2 that should really get the SBM rocket off the launch pad and to where us long term SBM shareholders have been awaiting it to go into the $ range.       

<< Previous
Bullboard Posts
Next >>